First human trial of coronavirus antibody treatment begins 

An Indiana-based pharmaceutical company announced Monday it has started the world’s first human trial of an antibody therapy designed to treat the coronavirus. Eli Lilly and Co said its potential treatment, known as LY-CoV555, is modeled after the antibodies found in the plasma of people who have recovered from the virus. The experimental treatment doesn’t…